Home > Annual Financials > SHUKRA PHARMACEUTICALS

SHUKRA PHARMACEUTICALS Financial Statement Analysis
[BOM: 524632]

The Revenues of SHUKRA PHARMACEUTICALS have increased by 74.01% YoY .
The Earnings Per Share (EPS) of SHUKRA PHARMACEUTICALS has increased by 127.27 % YoY.
COMMUNITY POLL
for SHUKRA PHARMACEUTICALS
Please provide your vote to see the results

SHUKRA PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 524632]

StandaloneMar2026
Mar2025
Mar2024
Mar2023
Mar2022
Revenues ₹57 Cr₹33 Cr₹75 Cr₹59 Cr₹20 Cr
Expenses ₹28 Cr₹20 Cr₹55 Cr₹53 Cr₹18 Cr
Operating Profit (Excl OI) ₹29 Cr₹13 Cr₹19 Cr₹5.36 Cr₹2.89 Cr
Other Income ₹4.59 Cr₹4.21 Cr₹2.82 Cr₹1.20 Cr₹0.08 Cr
Interest ₹1.15 Cr₹0.60 Cr₹0.29 Cr₹0.28 Cr₹0.29 Cr
Depreciation ₹3.44 Cr₹3.01 Cr₹2.05 Cr₹1.84 Cr₹1.66 Cr
Profit Before Tax ₹29 Cr₹13 Cr₹20 Cr₹4.44 Cr₹1.02 Cr
Profit After Tax ₹22 Cr₹9.58 Cr₹19 Cr₹4.41 Cr₹0.75 Cr
Earnings Per Share (Rs)₹0.50₹0.22₹16.94₹11.26₹4.79
PAT Margin (%)38.8829.3824.867.493.66
ROE(%)29.9415.9044.7021.164.70
ROCE(%)36.9821.8044.2418.855.79
Total Debt/Equity(x)0.060.070.050.200.21

Key Financials

Market Cap : ₹ 2,954.1 Cr
Revenue (TTM) : ₹ 74.8 Cr
Net Profit(TTM) : ₹ 36.0 Cr
EPS (TTM) : ₹ 0.8
P/E (TTM) : 82.0

Industry Peers & Returns1W1M1Y
SHUKRA PHARMACEUTICALS -0.3% 20.8% 102.5%
SUN PHARMACEUTICAL INDUSTRIES 0.2% -4.1% 5.5%
DIVIS LABORATORIES -3.1% -1.6% 47.3%
TORRENT PHARMACEUTICALS -1.2% -5% 29.4%
CIPLA 2.3% -2% -13.2%
DR REDDYS LABORATORIES 2.2% 6.2% -2.5%
MANKIND PHARMA -0.6% 2.9% -6%
LUPIN -0% -4.7% -0.1%
ZYDUS LIFESCIENCES 2.3% 3.8% 12.9%


SHUKRA PHARMACEUTICALS Revenues
[BOM: 524632]

Y-o-Y

74.01 %

5 Yr CAGR

28.99 %

Years Revenues % Change
Mar2026 ₹57 Cr
74.01
Mar2025 ₹33 Cr
-56.30
Mar2024 ₹75 Cr
26.75
Mar2023 ₹59 Cr
187.19
Mar2022 ₹20 Cr -


SHUKRA PHARMACEUTICALS Operating Profit
[BOM: 524632]

Y-o-Y

126.12 %

5 Yr CAGR

77.71 %

Years Operating Profit % Change
Mar2026 ₹29 Cr
126.12
Mar2025 ₹13 Cr
-34.39
Mar2024 ₹19 Cr
261.79
Mar2023 ₹5.36 Cr
85.83
Mar2022 ₹2.89 Cr -

Operating Margins
Y-o-Y

29.95 %

5 Yr CAGR

37.77 %

Years Operating Margin% % Change
Mar2026 50.76%
29.95
Mar2025 39.06%
50.12
Mar2024 26.02%
185.31
Mar2023 9.12%
-35.27
Mar2022 14.09% -

SHUKRA PHARMACEUTICALS Profit After Tax
[BOM: 524632]

Y-o-Y

130.27 %

5 Yr CAGR

132.77 %

Years Profit After Tax % Change
Mar2026 ₹22 Cr
130.27
Mar2025 ₹9.58 Cr
-48.35
Mar2024 ₹19 Cr
320.63
Mar2023 ₹4.41 Cr
486.82
Mar2022 ₹0.75 Cr -

PAT Margins
Y-o-Y

32.33 %

5 Yr CAGR

80.53 %

Years PAT Margin(%) % Change
Mar2026 38.88 %
32.33
Mar2025 29.38 %
18.18
Mar2024 24.86 %
231.91
Mar2023 7.49 %
104.64
Mar2022 3.66 % -

SHUKRA PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 524632]

Y-o-Y

127.27 %

5 Yr CAGR

-43.16 %

Years EPS % Change
Mar2026 ₹0.50
127.27
Mar2025 ₹0.22
-98.70
Mar2024 ₹17
50.44
Mar2023 ₹11
135.07
Mar2022 ₹4.79 -

SHUKRA PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 524632]

Y-o-Y

69.63 %

5 Yr CAGR

58.97 %

Years ROCE % Change
Mar2026 36.98%
69.63
Mar2025 21.8%
-50.72
Mar2024 44.24%
134.69
Mar2023 18.85%
225.56
Mar2022 5.79% -

SHUKRA PHARMACEUTICALS Share Price vs Sensex

Current Share Price : ₹66.8
Current MarketCap: ₹ 2,954.1 Cr
Updated EOD on :Oct 15,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
SHUKRA PHARMACEUTICALS

-0.3%

20.8%

102.5%

SENSEX

3.8%

-0.6%

-9.1%

SHUKRA PHARMACEUTICALS related INDICES

BSE Indices1W1M1Y
BSE HEALTHCARE -0.4% -5.7% 10.1%
No NSE index found

You may also like the below Video Courses


FAQ about SHUKRA PHARMACEUTICALS Financials


How the annual revenues of SHUKRA PHARMACEUTICALS have changed ?

The Revenues of SHUKRA PHARMACEUTICALS have increased by 74.01% YoY .

How the Earnings per Share (EPS) of SHUKRA PHARMACEUTICALS have changed?

The Earnings Per Share (EPS) of SHUKRA PHARMACEUTICALS has increased by 127.27 % YoY .